SCHEMBL6602294

SCHEMBL6602294

COc1ccc(C(=O)Nc2ccc3c(c2Br)CN(C(=O)C(F)(F)F)CC3)cc1C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.48
ESR2 Q92731 3/20 0.48
MAPT P10636 4/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PDE4D Q08499 1/20 0.41
TP53 P04637 2/20 0.40
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK1 P28482 1/20 0.39
HTR2C P28335 1/20 0.39
BRAF P15056 2/20 0.38
RAF1 P04049 1/20 0.38
ABCB1 P08183 1/20 0.38
S1PR1 P21453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8135404 0.93 ESR1 (0.42) ESR1ESR2MAPTKDM4ECYP1A2
SCHEMBL6604922 0.91 ESR1 (0.48) ESR1ESR2MAPTHDAC8HDAC6
SCHEMBL6602418 0.90 ESR1 (0.47) ESR1ESR2MAPTHDAC8HDAC6
SCHEMBL6601638 0.89 ESR1 (0.46) ESR1ESR2MAPTKDM4ECYP2C19
SCHEMBL6602301 0.88 HDAC8 (0.48) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL6603067 0.84 ESR1 (0.42) ESR1ESR2MAPTHDAC8HDAC6
SCHEMBL6604702 0.84 ESR1 (0.42) ESR1ESR2MAPTHDAC8HDAC6
SCHEMBL6602358 0.81 CREBBP (0.43) ESR1ESR2MAPTHDAC8HDAC6
SCHEMBL6601241 0.80 MAPT (0.44) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL7660349 0.79 PDE4D (0.41) MAPTKDM4ECYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed